Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

TAK-981 is an inhibitor of SUMO-activating enzyme (SAE; IC50 = <10 nM).1 It increases macrophage phagocytosis and natural killer (NK) cell-mediated cytotoxicity of cancer cells in vitro.2 TAK-981 upregulates the expression of IFN-regulated genes in the blood and tumor tissue in an A20 syngeneic lymphoma mouse model.3 It also decreases intratumor levels of SUMOlyated proteins and reduces tumor growth in the same model.
WARNING This product is not for human or veterinary use.
1. Heteroaryl compounds useful as inhibitors of sumo activating enzyme. WO2016/004136 Al, (2016).
2. Abstract 1523: Inhibition of SUMOylation by TAK-
3. Abstract 3079: Pharmacodynamic evaluation of the novel SUMOylation inhibitor TAK-